Keyphrases
Alcohol
12%
Alcohol Use Disorder
12%
Behavioral Response
12%
Chaperone Proteins
12%
Clinical Utility
12%
Dopamine D2 Receptor (DRD2)
12%
Dopamine Receptor 1
12%
Drug Discovery
100%
Drug Seeking
100%
Drugs of Abuse
12%
Eating Disorders
12%
Endoplasmic Reticulum
12%
Evidence Accumulation
12%
Excessive Consumption
12%
Food Seeking
100%
High Prevalence
12%
Highly Selective
12%
Morbidity Rate
12%
Mortality Rate
12%
Motivated Behavior
25%
Neurobiology
12%
Novel Medications
100%
Palatable Food
12%
Pharmacokinetic Profile
12%
Pharmacological Properties
12%
Plasma Membrane
12%
Potential Challenges
12%
Promising Target
12%
Psychiatric Disorders
12%
Psychostimulants
12%
Recent Advances
100%
Receptor System
100%
Receptor-based
25%
Reward Seeking
12%
Sigma-1 Receptor
100%
Sigma-1 Receptor Antagonist
37%
Structural Modeling
12%
Substance Use Disorder
12%
Therapeutic Avenues
12%
Therapeutic Intervention
12%
Translocated
12%
Treatment Options
12%
Pharmacology, Toxicology and Pharmaceutical Science
Chaperone
9%
Disease
18%
Dopamine 1 Receptor
9%
Dopamine Receptor D2
9%
Drug Dependence
9%
Drug Discovery
100%
Eating Disorder
9%
Ethanol
9%
G Protein Coupled Receptor
9%
Morbidity
9%
Mortality Rate
9%
Pharmacokinetics
9%
Prevalence
9%
Psychostimulant
9%
Receptor
100%
Receptor Antagonist
27%
Sigma 1 Opiate Receptor
100%
Neuroscience
Behavior (Neuroscience)
18%
Cell Membrane
9%
Chaperone
9%
Dopamine Receptor D1
9%
Dopamine Receptor D2
9%
Eating Disorder
9%
Eicosanoid Receptor
100%
Endoplasmic reticulum
9%
G Protein Coupled Receptor
9%
Neuroscience
9%
Pharmacokinetics
9%
Physical Dependence
9%
Psychostimulant
9%
Receptor Antagonist
27%
Sigma 1 Opiate Receptor
100%